January 4, 2018 / 1:12 PM / a year ago

BRIEF-Cellect Biotechnology Announces Clinical Results

Jan 4 (Reuters) - Cellect Biotechnology Ltd:

* CELLECT BIOTECHNOLOGY - ‍COMPLETED TRANSPLANTATION OF FIRST GROUP OF 3 PATIENTS USING CELLECT’S APOGRAFT TECHNOLOGY IN CO’S PHASE I/II CLINICAL TRIAL​

* CELLECT BIOTECHNOLOGY-‍AFTER 1 MONTH FOLLOW-UP, ALL 3 PATIENTS DEMONSTRATED ACCEPTANCE OF STEM CELL TRANSPLANT WITH NO ADVERSE EVENTS RELATED TO STUDY​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below